Mar 27
|
Merck’s Investigational Subcutaneous Pembrolizumab With Berahyaluronidase Alfa Demonstrates Noninferior Pharmacokinetics Compared to Intravenous (IV) KEYTRUDA® (pembrolizumab) in Pivotal 3475A-D77 Trial
|
Mar 27
|
Positive phase III data gives Merck potential boost for blockbuster Keytruda in injection form
|
Mar 27
|
Here is Why Jim Cramer Is Bullish About Merck (MRK)
|
Mar 26
|
Is Merck & Co., Inc. (MRK) the Best Consistent Dividend Stock to Buy?
|
Mar 26
|
Jim Cramer on Merck (MRK): “I Like It at This Level – But I Like Bristol-Myers Even More!”
|
Mar 26
|
Merck (NYSE:MRK) Gains EC Approval For CAPVAXIVE® Amid Recent 7% Share Price Dip
|
Mar 26
|
European Commission (EC) Approves Merck’s CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults
|
Mar 26
|
Why Merck & Co. Inc. (MRK) Performed Worst On Tuesday?
|
Mar 25
|
Is Merck & Co. Inc. (MRK) The Best Defensive Stock Amid Market Volatility?
|
Mar 25
|
Merck Bets $2B on China's Hengrui for Next Big Heart Drug
|
Mar 25
|
Merck Will Pay Up to $2 Billion for Chinese Heart Drug
|
Mar 25
|
Trump tariffs drive pharma manufacturing to US but risk inflation and disruption
|
Mar 25
|
Is Weakness In Merck & Co., Inc. (NYSE:MRK) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
|
Mar 25
|
Merck bets $200M on a new type of heart pill
|
Mar 21
|
3 of Goldman Sachs' best investing tips for currently volatile markets
|
Mar 20
|
Merck (NYSE:MRK) Unveils New Data On Cardiovascular Advances At ACC.25 Annual Conference
|
Mar 20
|
Merck & Co., Inc. (MRK): Among Incredibly Cheap Dividend Stock to Buy Now
|
Mar 19
|
Why Merck & Co. (MRK) Is Among the Most Undervalued Biotech Stocks to Invest In
|
Mar 19
|
Merck Loses Almost $52B in 6 Months: How to Play MRK Stock
|
Mar 19
|
Actinium Pharmaceuticals launches clinical trial for Actimab-A in combination
|